Compare NNNN & GOOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NNNN | GOOS |
|---|---|---|
| Founded | 2021 | 1957 |
| Country | Germany | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2025 | 2017 |
| Metric | NNNN | GOOS |
|---|---|---|
| Price | $33.50 | $12.91 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $12.80 |
| AVG Volume (30 Days) | 37.4K | ★ 957.6K |
| Earning Date | 04-28-2026 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.06 | ★ 0.19 |
| Revenue | $6,920,153.00 | ★ $984,644,735.00 |
| Revenue This Year | N/A | $8.87 |
| Revenue Next Year | N/A | $5.93 |
| P/E Ratio | $554.67 | ★ $66.01 |
| Revenue Growth | N/A | ★ 3.71 |
| 52 Week Low | $5.18 | $6.73 |
| 52 Week High | $55.65 | $15.43 |
| Indicator | NNNN | GOOS |
|---|---|---|
| Relative Strength Index (RSI) | 49.21 | 45.73 |
| Support Level | $32.93 | $12.90 |
| Resistance Level | $43.00 | $13.61 |
| Average True Range (ATR) | 4.09 | 0.59 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 33.23 | 12.50 |
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
Canada Goose Holdings Inc is a Canada-based company that designs, manufactures, distributes, and retails premium outerwear for men, women, and children. It operates business through three segments namely, Wholesale and Direct to Consumer (DTC), Other. The DTC segment, which is the key revenue driver, comprises sales through country-specific e-commerce platforms and its company-owned retail stores located in luxury shopping locations. The Wholesale segment comprises sales made to a mix of retailers and international distributors, who are partners that have exclusive rights to an entire market, and travel retail locations. Geographically, it has a presence in Canada, the United States, North America, Greater China, Asia, and Europe, the Middle East, and Africa.